ADACEL®


Suspension for Injection 10 x 0 5 mL vials
scheduling status
S2
registration number
51/30.1/0837
What ADACEL® is and what it is used for
ADACEL (Tdap) is indicated for active booster immunisation for the prevention of tetanus, diphtheria and pertussis (whooping cough) in persons 4 years of age and older, according to local immunisation recommendations. Passive immunisation against pertussis in early infancy following maternal immunisation during pregnancy (see sections 4.2, 4.6 and 5.1). Persons who have had pertussis, tetanus or diphtheria, should still be immunised since these clinical infections do not always confer immunity. ADACEL can be used in the management of tetanus prone injuries with or without concomitant administration of tetanus immunoglobulin in accordance with official recommendations.
dosage
ADACEL (0,5 mL) should be administered as a booster injection by the intramuscular route. Re-dosing with ADACEL can be used to boost immunity to diphtheria, tetanus and pertussis at 5- to 10-year intervals. ADACEL may be administered to pregnant women during the second and third trimester to provide passive immunity to infants against pertussis (see sections 4.1, 4.6 and 5.1).
how to take
Administer the total volume of 0,5 mL intramuscularly (IM). The preferred site of injection is the deltoid muscle. Fractional doses (doses < 0,5 mL) should not be given. Do not administer ADACEL intravenously. ADACEL should not be administered into the gluteal area; intradermal or subcutaneous routes should not be used (for exception see section 4.4). For instructions on handling of ADACEL before administration see section 6.6.
What ADACEL® contains
Each 0,5 mL dose contains: Tetanus toxoid (T) 5 Lf (not less than 20 IU*) Diphtheria toxoid (d) 2 Lf (not less than 2 IU*) Pertussis toxoid (PT) 2,5 micrograms Filamentous haemagglutinin (FHA) 5 micrograms Pertactin (PRN) 3 micrograms Fimbriae types 2 and 3 (FIM) 5 micrograms * As lower confidence limit (p = 0,95) of activity measured according to the assay described in the European Pharmacopoeia. Sugar free.
other ingredients
Aluminum phosphate (adjuvant) 1,5 mg (0,33 mg Al3+) 2-phenoxyethanol (not as preservative) 3,3 mg (0,6 % v/v) Water for injection Other ingredients per dose include ≤ 5 micrograms residual formaldehyde and < 50 nanograms residual glutaral.
Therapeutic classification
J07AJ52.
© 2026 SAHPRA. ALL RIGHTS RESERVED